LAMICTAL 50 MG COMPRIMIDOS MASTICABLES/DISPERSABLES

Glaxosmithkline Gmbh & Co. Kg🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 287f4bc9e94425dc
Drug Cima Aemps Name: LAMICTAL 50 MG COMPRIMIDOS MASTICABLES/DISPERSABLES
Register Number: 331220200IP1
Holder Company Name: Glaxosmithkline Gmbh & Co. Kg
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/glaxosmithkline-gmbh-and-co-kg
Authorization Date: 2025-05-09
Dosage Form: COMPRIMIDO MASTICABLE Y DISPERSABLE
Dose: 50 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized: No
Company Name: Glaxosmithkline Gmbh & Co. Kg
Company Detail Path: /organization/glaxosmithkline-gmbh-and-co-kg

LAMOTRIGINA

50 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 9, 2025

Approval ID

287f4bc9e94425dc

Type

Standard